Therefore, we believe that Cr/Ccr can be used as an indicator of OCT2, MATE1 and P-gp transporter expression, and its changes are significantly correlated with OCT2, MATE1 and P-gp changes, providing data and references for clinical renal disease patients in clinical medication. This evidence concerns the gene PGP and kidney disorder.